When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. He Jiankui genome editing incident - Wikipedia

    en.wikipedia.org/wiki/He_Jiankui_genome_editing...

    On 26 November 2018, The CRISPR Journal published ahead of print an article by He, Ryan Ferrell, Chen Yuanlin, Qin Jinzhou, and Chen Yangran in which the authors justified the ethical use of CRISPR gene editing in humans. [74] As the news of CRISPR babies broke out, the editors reexamined the paper and retracted it on 28 December, announcing:

  3. Human germline engineering - Wikipedia

    en.wikipedia.org/wiki/Human_germline_engineering

    On 30 December 2019, a Chinese district court found He Jiankui guilty of illegal practice of medicine, sentencing him to three years in prison with a fine of 3 million yuan. [ 35 ] [ 36 ] Zhang Renli and Qin Jinzhou received an 18-month prison sentence and a 500,000-yuan fine, and were banned from working in assisted reproductive technology for ...

  4. CRISPR gene editing - Wikipedia

    en.wikipedia.org/wiki/CRISPR_gene_editing

    The work was widely condemned as unethical, dangerous, and premature. [280] An international group of scientists called for a global moratorium on genetically editing human embryos. [281] Designer babies. The advent of CRISPR-Cas9 gene editing technology has led to the possibility of creating "designer babies."

  5. 1 Biotech Stock Down 62% to Buy and Hold

    www.aol.com/1-biotech-stock-down-62-124500519.html

    CRISPR and Vertex estimate there is an addressable market of 35,000 patients in the U.S. and Europe and another 23,000 in Saudi Arabia and Bahrain. Casgevy costs $2.2 million in the U.S., a pretty ...

  6. Why Is CRISPR Therapeutics AG (CRSP) Up 45.9% Since Last ...

    www.aol.com/news/why-crispr-therapeutics-ag-crsp...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Hwang affair - Wikipedia

    en.wikipedia.org/wiki/Hwang_affair

    The Hwang affair, [1] or Hwang scandal, [2] or Hwanggate, [3] is a case of scientific misconduct and ethical issues surrounding a South Korean biologist, Hwang Woo-suk, who claimed to have created the first human embryonic stem cells by cloning in 2004.

  8. Down 47% Since March, Is CRISPR Therapeutics Stock a ... - AOL

    www.aol.com/finance/down-47-since-march-crispr...

    CRISPR Therapeutics has a $3.9 billion market cap at recent prices, but the stock is less expensive than it looks on the surface. With a big cash cushion and a lack of debt, its enterprise value ...

  9. Hazards of synthetic biology - Wikipedia

    en.wikipedia.org/wiki/Hazards_of_synthetic_biology

    Given the overlap between synthetic biology and the do-it-yourself biology movement, concerns have been raised that its practitioners may not abide by risk assessment and biosafety practices required of professionals, [2]: 39 although it has been suggested that an informal code of ethics exists that recognizes health risks and other adverse ...